Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma - sprookjes - yvandenbroek - TriplyDB

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

http://www.wikidata.org/entity/Q34887442

about

What you always needed to know about electroporation based DNA vaccines Harnessing the immune system to improve cancer therapy Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12 Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors Interleukin 12: still a promising candidate for tumor immunotherapy?Electrochemotherapy: from the drawing board into medical practice In-situ tumor vaccination: Bringing the fight to the tumor Endocytosis and Endosomal Trafficking of DNA After Gene Electrotransfer In Vitro.High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma Emerging ideas: Interleukin-12 nanocoatings prevent open fracture-associated infections Interleukin 12 a key immunoregulatory cytokine in infection applications A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells Evaluation of a novel non-penetrating electrode for use in DNA vaccination Novel delivery approaches for cancer therapeutics.Sonoporation: Gene transfer using ultrasound Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease Physically facilitating drug-delivery systems.Electroporation advances in large animals.The actin cytoskeleton has an active role in the electrotransfer of plasmid DNA in mammalian cells.Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells.Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells.Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.An electrically active microneedle array for electroporation.New insights into the mechanisms of gene electrotransfer--experimental and theoretical analysis Advancement and prospects of tumor gene therapy Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter.Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.Pathogen-driven cancers and emerging immune therapeutic strategies.Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses.Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.New insights into IL-12-mediated tumor suppression.Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid.

P2860

Q24602340-F62C8442-3D1F-4585-9B44-F489154C41AB Q26738698-CA07E8BC-276D-49B5-960E-A1683F1932BD Q26796316-3DA2D0E2-35FA-4F82-9ECD-478A011DFE18 Q26822537-74213411-18EA-4EC0-82FB-8ACEF43EA297 Q26861559-AEF7677B-C472-4517-99A8-BBE9F2142359 Q26863455-0F782003-C252-4FD4-BA30-EF1AED05D964 Q26991976-C4FAEF5C-C723-4809-AB62-6D523671B7F4 Q27317318-C6781DB4-99FA-4EF9-A49A-4E5BDC09BC5F Q27497251-1A92914A-F412-4728-8E99-82656554D5E6 Q28071998-543E5C31-16C7-4F16-B28C-C22BBFCA9D8B Q28392292-FC2BEE36-7B8E-4F1A-8745-9B1004A618B0 Q28395500-C5646C76-FDDA-4A36-B42F-C693F2113AEF Q28541799-4050409E-C35E-4589-B348-3FA26BEC865B Q28652428-624F15EA-E530-42AB-8B7F-5BB9067F8A2D Q28740588-901ED788-CF39-4DEE-84E5-F68852E00F86 Q30368171-BB934724-94E8-4EB7-A96B-0DC87DE09502 Q30430739-5579306C-4D7C-422E-BA94-17124F8A6B5B Q30449821-E67B5E10-BC97-419E-90DF-6B6B82E51F79 Q30462003-17EA65C0-B7B8-4AA8-9FFC-8B58C6777A68 Q30476834-AA2E0A44-07B8-4EDF-850C-A114BCF0C5C3 Q30500347-4D1ACFDD-9E05-40B0-A7FF-8199D8255CFF Q30501927-0D45A8F0-C56D-41D9-BCDA-0831973E1C20 Q33497050-0BF57C5C-B174-4199-B395-20678ACF6200 Q33507532-E0168C89-755C-4BE1-8214-3646BD4A47E6 Q33518647-4A8C97FF-6403-464C-9821-315EFF61FE34 Q33562379-C738AD39-6BA5-4DFF-8D0C-2138BC175198 Q33579330-13676458-9875-4683-ACF7-E035A584E386 Q33614476-143C65FB-3C48-4BC3-A895-4336A0088F27 Q33713435-14F88975-5680-45FA-8B80-FF1DBB0ADD29 Q33713915-5021CD3C-F1B5-40CB-A66E-6AC1ADE05F28 Q33741348-A43C0FC5-9B6C-42B0-9C7D-FCC2E9BA6FE4 Q33832131-0DF2418A-0C72-4964-A883-383A2AF9A6AF Q33835146-C9029DE6-79A3-4945-8BD6-DD6EE40478C5 Q34054175-2E44E3C3-1D4A-45D3-B7E2-103D143A8E1D Q34111151-E1CC9710-9A5E-4691-A98D-86CC640C14DB Q34117131-9D798493-073F-4219-9F84-C1DB1BCFEEFE Q34311495-3C382B82-6E94-4ABD-824F-40AB058009A5 Q34428875-AC8541F6-616D-42F2-A869-E7EC176D1ED8 Q34436897-BF2C0966-CBE8-4C52-BBD6-6F94376FECB7 Q34469496-A67F539A-FAC5-4EF1-9B1D-A0336A04DA1F

P2860

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

http://www.wikidata.org/entity/Q34887442

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@ast

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@en

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@nl

type

label

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@ast

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@en

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@nl

prefLabel

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@ast

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@en

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@nl

P1433

Q34887442-836C3AA8-ABD3-4F9C-B0EA-D1DAD2DDFE15

P1476

Q34887442-3FE32AE8-FD13-4C80-B01E-BAB06D884D75

P2093

Q34887442-1190B7F2-024E-474F-AE09-BC9459D04239

Q34887442-2E4B4022-8DD5-40A5-AE82-CD6CFE9F23DA

Q34887442-4BD43F81-3AE5-4093-A4F9-185D41CCCF8A

Q34887442-51605064-89B3-44C2-8F4F-FD635E2A73AB

Q34887442-70E503A6-6F9B-4635-B884-7A300C4984E2

Q34887442-717DDA36-86BD-4EE9-ADD6-7B44D68D9D0B

Q34887442-7231D0AB-ED0D-4804-89FE-69081ADB3838

Q34887442-780CFC70-31F8-42DF-A833-954E0299BB86

Q34887442-8561CA88-9A8F-42AF-B4A5-E260FC98FF93

Q34887442-F97150B1-33D4-406F-812A-7D9AA05CAA1C

P2860

Q34887442-00AEE762-5C3B-4CC5-8230-139C6733A66E

Q34887442-031D1951-36BB-4A54-9BA3-01F92787416C

Q34887442-09A4C064-2F39-4BB9-853A-69E3F466DAAF

Q34887442-0DA011F5-43CA-4EF6-BB0E-84CF05227E63

Q34887442-1C1DAE6E-C0DE-4A7B-A885-C427FB831753

Q34887442-27F13B3A-4D90-4F5A-B842-72B43C9303D1

Q34887442-335830E2-2B2E-4498-85BF-FCB5F6EF5034

Q34887442-3A701634-5F38-42D1-B6B2-D26EABBC8CBE

Q34887442-3BD6EFAB-0245-41CD-8DC7-D873E85766AD

Q34887442-45269624-DAEA-4419-A73B-C97821FEA7B9

P304

Q34887442-CE1771D6-4829-493A-A605-5E56F7ED8569

P31

Q34887442-6DFA6586-55FD-41D8-8F8E-4432831CAF14

P356

Q34887442-2CE62645-6D31-4273-B1AE-8CF7DF64645B

P407

Q34887442-A6CE193A-8590-40CD-89FD-97010ECBB7E5

P433

Q34887442-7EEAED8D-6BCA-492E-B6E1-32F64974EA10

P478

Q34887442-D24522A1-D044-4D70-8E88-6AD512BAB11F

P50

Q34887442-D12D4CBE-F151-42AE-9581-078BF52398FC

P577

Q34887442-51CCCA39-755E-413E-B2EE-E4663F8D2992

P698

Q34887442-7184A471-F6E6-4919-A49A-3F272BC2A5BA

P921

Q34887442-11569F8D-7485-469E-AE63-2B352AF5BB47

Q34887442-4CA0B150-8947-45D5-A9B8-56D487F8ADE4

Q34887442-6921fae1-198b-4f6f-888e-050393faf9e7

Q34887442-8E1B373F-89CD-4E47-8BA2-DB48FE385F68

P932

Q34887442-4292225D-073A-4D4F-BD1F-EBA39EE5CE30

P356

JCO.2007.15.6794

P1433

Journal of Clinical Oncology

P1476

Phase I trial of interleukin-1 ...... ients with metastatic melanoma

@en

P2093

Adam I Riker

http://www.w3.org/2001/XMLSchema#string

Daniel M Sullivan

http://www.w3.org/2001/XMLSchema#string

Jane L Messina

http://www.w3.org/2001/XMLSchema#string

Kenneth E Ugen

http://www.w3.org/2001/XMLSchema#string

Pamela N Munster

http://www.w3.org/2001/XMLSchema#string

Patricia Urbas

http://www.w3.org/2001/XMLSchema#string

Richard Heller

http://www.w3.org/2001/XMLSchema#string

Ronald C DeConti

http://www.w3.org/2001/XMLSchema#string

Stephanie Andrews

http://www.w3.org/2001/XMLSchema#string

Vernon K Sondak

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer statistics, 2007

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.

Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation.

Immunotherapy as part of a multidisciplinary approach to melanoma treatment.

Viral gene therapy strategies: from basic science to clinical application.

Gene therapy of cancer based on interleukin 12.

Current advances and future challenges in Adenoviral vector biology and targeting

P304

5896-5903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.15.6794

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19029422

http://www.w3.org/2001/XMLSchema#string

P921

electroporation

phase I clinical trial

P932

2645111

http://www.w3.org/2001/XMLSchema#string